Transanal hemorrhoidal dearterialization (THD): a safe procedure for the anticoagulated patient?

S Atallah, G K Maharaja, B Martin-Perez, J P Burke, M R Albert, S W Larach, S Atallah, G K Maharaja, B Martin-Perez, J P Burke, M R Albert, S W Larach

Abstract

Background: Approximately one in five persons living in the USA is maintained on oral anticoagulation. It has typically been recommended that anticoagulation be withheld prior to hemorrhoidal procedures. Transanal hemorrhoidal dearterialization (THD) is a minimally invasive treatment for symptomatic hemorrhoids, and outcomes with patients on anticoagulation who have undergone this procedure have not been previously reported. Here, we report our preliminary results of patients who underwent THD while on anticoagulation.

Methods: During a 53-month period (February 2009-July 2015), patients with symptomatic hemorrhoids refractory to medical management who underwent surgical treatment with THD were retrospectively reviewed. The subset of patients who underwent THD while anticoagulated was compared to a cohort of patient who were not taking anticoagulation and who otherwise demonstrated normal coagulation profiles and who did not have a known predisposition to bleeding or inherited coagulopathy. The primary study endpoint was to assess postoperative bleeding in patients who were maintained on anticoagulation before and after surgery.

Results: During the 53-month study period, 106 patients underwent the THD procedure for symptomatic hemorrhoids. Of these, seventy patients underwent THD without anticoagulation therapy, while 36 patients underwent THD while taking one or more oral anticoagulants. The postoperative morbidity between the two cohorts was similar, and specifically there was no statistical difference in the rate of postoperative hemorrhage (19.4 vs. 15.7 %; odds ratio 1.295, 95 % CI 0.455-3.688, p = 0.785). No patient, in either cohort, required re-intervention for any reason during the study period. Patients who underwent THD while on anticoagulation were less likely to have recurrent hemorrhoidal disease during the study's 6-month median follow-up period (2.8 vs. 7.1 %, p = 0.049).

Conclusions: These preliminary data reveal that THD can be performed on anticoagulated patients without cessation of oral agents without increasing morbidity from postoperative bleeding.

Keywords: Anticoagulation; Hemorrhoids; Postoperative hemorrhage; THD; Transanal hemorrhoidal dearterialization.

References

    1. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among US adults: behavioral risk factor surveillance system. Am J Prev Med. 2006;30:74–77. doi: 10.1016/j.amepre.2005.08.042.
    1. Anita Soni (2005) Aspirin use among the adult U.S. noninstitutionalized population, with and without indicators of heart disease. Statistical Brief #179.
    1. Topol EJ, Schork NJ. Catapulting clopidogrel pharmacogenomics forward. Nat Med. 2011;17:40–41. doi: 10.1038/nm0111-40.
    1. Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol. 2006;62:509–511. doi: 10.1111/j.1365-2125.2006.02806.x.
    1. Di Nisio M, Middeldorp S, Büller H. Direct thrombin inhibitors. N Engl J Med. 2005;353:1028–1040. doi: 10.1056/NEJMra044440.
    1. Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet Alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;17:2413–2424. doi: 10.1056/NEJMoa1510991.
    1. Fox A, Tietze PH, Ramakrishnan K. Anorectal conditions: hemorrhoids. FP Essent. 2014;419:11–19.
    1. Cataldo P, Ellis CN, Gregorcyk S, et al. Standards Practice Task Force, The American Society of Colon and Rectal Surgeons, USA. Practice parameters for the management of hemorrhoids (revised) Dis Colon Rectum. 2005;48:189–194. doi: 10.1007/s10350-004-0921-4.
    1. Wang Q, Cai C, Dong W, Du J. Severe intra-abdominal bleeding leading to hemorrhagic shock, rectal perforation and bilateral hydrothorax after stapling procedure for prolapsed hemorrhoids. Tech Coloproctol. 2014;18:771–772. doi: 10.1007/s10151-013-1120-x.
    1. Festen S, van Hoogstraten MJ, van Geloven AA, Gerhards MF. Treatment of grade III and IV haemorrhoidal disease with PPH or THD. A randomized trial on postoperative complications and short-term results. Int J Colorectal Dis. 2009;24:1401–1405. doi: 10.1007/s00384-009-0803-2.
    1. Odelowo O, Mekasha G, Johnson MA. Massive life-threatening lower gastrointestinal hemorrhage following hemorrhoidal rubber band ligation. J Natl Med Assoc. 2002;94:1089–1092.
    1. Patel S, Shahzad G, Rizvon K, Subramani K, Viswanathan P, Mustacchia P. Rectal ulcers and massive bleeding after hemorrhoidal band ligation while on aspirin. World J Clin Cases. 2014;16:86–89. doi: 10.12998/wjcc.v2.i4.86.
    1. Bat L, Melzer E, Koler M, Dreznick Z, Shemesh E. Complications of rubber band ligation of symptomatic internal hemorrhoids. Dis Colon Rectum. 1993;36:287–290. doi: 10.1007/BF02053512.
    1. Chen HH, Wang JY, Changchien CR, et al. Risk factors associated with posthemorrhoidectomy secondary hemorrhage: a single-institution prospective study of 4880 consecutive closed hemorrhoidectomies. Dis Colon Rectum. 2002;45:1096–1099. doi: 10.1007/s10350-004-6366-y.
    1. Rosen L, Sipe P, Stasik JJ, Riether RD, Trimpi HD. Outcome of delayed hemorrhage following surgical hemorrhoidectomy. Dis Colon Rectum. 1993;36:743–746. doi: 10.1007/BF02048364.
    1. De Nardi P, Capretti G, Corsaro A, Staudacher C. A prospective, randomized trial comparing the short- and long-term results of doppler-guided transanal hemorrhoid dearterialization with mucopexy versus excision hemorrhoidectomy for grade III hemorrhoids. Dis Colon Rectum. 2014;57:348–353. doi: 10.1097/DCR.0000000000000085.
    1. Ratto C, Parello A, Veronese E, et al. Doppler-guided transanal haemorrhoidal dearterialization for haemorrhoids: results from a multicentre trial. Colorectal Dis. 2015;17:O10–O19. doi: 10.1111/codi.12779.
    1. Denoya P, Tam J, Bergamaschi R. Hemorrhoidal dearterialization with mucopexy versus hemorrhoidectomy: 3-year follow-up assessment of a randomized controlled trial. Tech Coloproctol. 2014;18:1081–1085. doi: 10.1007/s10151-014-1219-8.
    1. Cavazzoni E, Bugiantella W, Graziosi L, et al. Emergency transanal haemorrhoidal Doppler guided dearterialization for acute and persistent haemorrhoidal bleeding. Colorectal Dis. 2013;15:e89–e92. doi: 10.1111/codi.12053.
    1. Goligher JC, Leacock AG, Brossy JJ. The surgical anatomy of the anal canal. Br J Surg. 1955;43:51–61. doi: 10.1002/bjs.18004317707.
    1. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;22:1506–1511. doi: 10.1056/NEJM199705223362107.
    1. Douketis JD, Crowther MA, Cherian SS, Kearon CB. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest. 1999;1:1240–1246. doi: 10.1378/chest.116.5.1240.
    1. Sherwood MW, Nessel CC, Hellkamp AS, et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF Trial. J Am Coll Cardiol. 2015;1:2271–2281. doi: 10.1016/j.jacc.2015.09.024.
    1. Abraham NS, Singh S, Alexander GC, et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ. 2015;24:h1857. doi: 10.1136/bmj.h1857.
    1. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haemotol. 1996;1:479–485. doi: 10.1046/j.1365-2141.1996.d01-1499.x.
    1. Harenberg J, Haas R, Zimmermann R. Plasma hypercoagulability after termination of oral anticoagulants. Thromb Res. 1983;15:627–633. doi: 10.1016/0049-3848(83)90217-7.
    1. Sise HS, Moschos CB, Gauthier J, Becker R. The risk of interrupting long-term anticoagulant treatment a rebound hypercoagulable state following hemorrhage. Circulation. 1961;1:1137–1142. doi: 10.1161/01.CIR.24.5.1137.
    1. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;8:1009–1019. doi: 10.1056/NEJMoa067722.
    1. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;19:2584–2591. doi: 10.1016/j.jacc.2006.10.026.
    1. Cannegieter SC, Rosendaal FR, Wintzen AR, Van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;6:11–17. doi: 10.1056/NEJM199507063330103.
    1. Hammerstingl C, Tripp C, Schmidt H, von der Recke G, Omran H. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis. 2007;16:285–292.
    1. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart. J Am Coll Cardiol. 2006;16:2130–2139. doi: 10.1016/j.jacc.2006.04.026.
    1. Larsen TB, Lip GY, Gorst-Rasmussen A. Anticoagulant therapy after venous thromboembolism and 10-year mortality. Int J Cardiol. 2016;18:72–78. doi: 10.1016/j.ijcard.2016.01.190.
    1. Douketis JD, Healey JS, Brueckmann M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost. 2015;113:625–632. doi: 10.1160/TH14-04-0305.
    1. Kozek-Langenecker SA. Perioperative management issues of direct oral anticoagulants. Semin Hematol. 2014;51:112–120. doi: 10.1053/j.seminhematol.2014.02.001.
    1. Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT) J Thromb Haemost. 2007;1:2211–2218. doi: 10.1111/j.1538-7836.2007.02729.x.
    1. Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern. 2004;28:1319–1326. doi: 10.1001/archinte.164.12.1319.
    1. Hammerstingl C, Schmitz A, Fimmers R, Omran H. Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry. Cardiovasc Ther. 2009;1:230–238. doi: 10.1111/j.1755-5922.2009.00099.x.
    1. Spyropoulos AC, Jenkins P, Bornikova L. A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation. Pharmacotherapy. 2004;24:649–658. doi: 10.1592/phco.24.6.649.34740.
    1. Seshadri N, Goldhaber SZ, Elkayam U, et al. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J. 2005;1:27–34. doi: 10.1016/j.ahj.2004.11.018.
    1. Serebruany VL, Steinhubl SR, Berger PB, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol. 2005;15:1218–1222. doi: 10.1016/j.amjcard.2005.01.049.
    1. Nelson RS, Thorson AG. Risk of bleeding following hemorrhoidal banding in patients on antithrombotic therapy. Gastroenterol Clin Biol. 2009;33:463–465. doi: 10.1016/j.gcb.2009.05.007.
    1. Iyer VS, Shrier I, Gordon PH. Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum. 2004;1:1364–1370. doi: 10.1007/s10350-004-0591-2.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren